In the report, two patients on glucagon-like peptide 1 (GLP-1) agonists had significant gastric contents during elective gastroscopy despite adequate fasting
Relative validity and reliability of a diet risk score (DRS) for clinical practice
Oral GLP-1 biologics (e.g., in early development at Biora and Viking) or small molecule GLP-1R agonists (e.g., Structure Therapeutics), will further improve patient adherence and facilitate clinical uptake of these medications
A gastric emptying scintigraphy test commonly tracks a small amount of safe radioactive material mixed into a meal
Detailed information regarding drug exposure and drug treatment indication, including dose, timing of therapy initiation, duration and concurrent medications, is also documented during the initial contact with the TIS
They are produced on a patient-specific basis based on a prescription from a licensed healthcare provider